Cargando…

Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1–3N0M0

BACKGROUND: The postoperative survival effect of the number of examined lymph nodes on patients of R0-resected esophageal squamous cell carcinoma with pathological stage T1–3N0M0 is still unclear. METHODS: Patients diagnosed with pathological stage T1–3N0M0 esophageal squamous cell carcinoma from tw...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Lei-Lei, Zhong, Jiu-Di, Zhu, Jia-Li, Kang, Lu, Huang, Yang-Yu, Lin, Peng, Long, Hao, Zhang, Lan-Jun, Ma, Qi-Long, Qiu, Li-Hong, Ma, Guo-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800278/
https://www.ncbi.nlm.nih.gov/pubmed/35090428
http://dx.doi.org/10.1186/s12885-022-09207-x
_version_ 1784642226055282688
author Wu, Lei-Lei
Zhong, Jiu-Di
Zhu, Jia-Li
Kang, Lu
Huang, Yang-Yu
Lin, Peng
Long, Hao
Zhang, Lan-Jun
Ma, Qi-Long
Qiu, Li-Hong
Ma, Guo-Wei
author_facet Wu, Lei-Lei
Zhong, Jiu-Di
Zhu, Jia-Li
Kang, Lu
Huang, Yang-Yu
Lin, Peng
Long, Hao
Zhang, Lan-Jun
Ma, Qi-Long
Qiu, Li-Hong
Ma, Guo-Wei
author_sort Wu, Lei-Lei
collection PubMed
description BACKGROUND: The postoperative survival effect of the number of examined lymph nodes on patients of R0-resected esophageal squamous cell carcinoma with pathological stage T1–3N0M0 is still unclear. METHODS: Patients diagnosed with pathological stage T1–3N0M0 esophageal squamous cell carcinoma from two cancer databases—our cancer center (N = 707), and Surveillance Epidemiology and End Results (N = 151). The primary clinical endpoint was overall survival. The X-tile software was used to determine the optimal cutoff value of the number of examined lymph nodes, and propensity score matching was conducted to reduce selection bias according to the results of X-tile software. The cohort of 151 patients from another database was used for validation. RESULTS: X-tile software provided an optimal cutoff value of 15 examined lymph nodes based on 707 patients, and 231 pairs of matched patients were included. In the unmatched cohort, Cox proportional hazard regression analysis revealed better overall survival in patients with more than 15 examined lymph nodes (adjusted hazard ratio, 0.566, 95% confidence interval, 0.445–0.720; p < 0.001) compared with patients with 15 or fewer examined lymph nodes. In the validation cohort, patients with more than 15 examined lymph nodes also had better overall survival (adjusted hazard ratio 0.665, p = 0.047). CONCLUSIONS: The number of examined lymph nodes is a significant prognostic factor in esophageal squamous cell carcinoma patients with pathological stage T1–3N0M0, and more than 15 examined lymph nodes are associated with better overall survival. Although the difference is not significant, the survival curve of patients with examined lymph nodes > 30 is better than those with examined lymph nodes 15–30. We believe that the number of examined lymph nodes can provide prognostic guidance for those patients, and the more examined lymph nodes cause lesser occult lymph nodes metastasis and lead to a better prognosis. Therefore, surgeons and pathologists should try to examine as many lymph nodes as possible to evaluate the pathological stage precisely. However, we need more validation from other studies.
format Online
Article
Text
id pubmed-8800278
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88002782022-02-02 Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1–3N0M0 Wu, Lei-Lei Zhong, Jiu-Di Zhu, Jia-Li Kang, Lu Huang, Yang-Yu Lin, Peng Long, Hao Zhang, Lan-Jun Ma, Qi-Long Qiu, Li-Hong Ma, Guo-Wei BMC Cancer Research BACKGROUND: The postoperative survival effect of the number of examined lymph nodes on patients of R0-resected esophageal squamous cell carcinoma with pathological stage T1–3N0M0 is still unclear. METHODS: Patients diagnosed with pathological stage T1–3N0M0 esophageal squamous cell carcinoma from two cancer databases—our cancer center (N = 707), and Surveillance Epidemiology and End Results (N = 151). The primary clinical endpoint was overall survival. The X-tile software was used to determine the optimal cutoff value of the number of examined lymph nodes, and propensity score matching was conducted to reduce selection bias according to the results of X-tile software. The cohort of 151 patients from another database was used for validation. RESULTS: X-tile software provided an optimal cutoff value of 15 examined lymph nodes based on 707 patients, and 231 pairs of matched patients were included. In the unmatched cohort, Cox proportional hazard regression analysis revealed better overall survival in patients with more than 15 examined lymph nodes (adjusted hazard ratio, 0.566, 95% confidence interval, 0.445–0.720; p < 0.001) compared with patients with 15 or fewer examined lymph nodes. In the validation cohort, patients with more than 15 examined lymph nodes also had better overall survival (adjusted hazard ratio 0.665, p = 0.047). CONCLUSIONS: The number of examined lymph nodes is a significant prognostic factor in esophageal squamous cell carcinoma patients with pathological stage T1–3N0M0, and more than 15 examined lymph nodes are associated with better overall survival. Although the difference is not significant, the survival curve of patients with examined lymph nodes > 30 is better than those with examined lymph nodes 15–30. We believe that the number of examined lymph nodes can provide prognostic guidance for those patients, and the more examined lymph nodes cause lesser occult lymph nodes metastasis and lead to a better prognosis. Therefore, surgeons and pathologists should try to examine as many lymph nodes as possible to evaluate the pathological stage precisely. However, we need more validation from other studies. BioMed Central 2022-01-28 /pmc/articles/PMC8800278/ /pubmed/35090428 http://dx.doi.org/10.1186/s12885-022-09207-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wu, Lei-Lei
Zhong, Jiu-Di
Zhu, Jia-Li
Kang, Lu
Huang, Yang-Yu
Lin, Peng
Long, Hao
Zhang, Lan-Jun
Ma, Qi-Long
Qiu, Li-Hong
Ma, Guo-Wei
Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1–3N0M0
title Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1–3N0M0
title_full Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1–3N0M0
title_fullStr Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1–3N0M0
title_full_unstemmed Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1–3N0M0
title_short Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1–3N0M0
title_sort postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage t1–3n0m0
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800278/
https://www.ncbi.nlm.nih.gov/pubmed/35090428
http://dx.doi.org/10.1186/s12885-022-09207-x
work_keys_str_mv AT wuleilei postoperativesurvivaleffectofthenumberofexaminedlymphnodesonesophagealsquamouscellcarcinomawithpathologicalstaget13n0m0
AT zhongjiudi postoperativesurvivaleffectofthenumberofexaminedlymphnodesonesophagealsquamouscellcarcinomawithpathologicalstaget13n0m0
AT zhujiali postoperativesurvivaleffectofthenumberofexaminedlymphnodesonesophagealsquamouscellcarcinomawithpathologicalstaget13n0m0
AT kanglu postoperativesurvivaleffectofthenumberofexaminedlymphnodesonesophagealsquamouscellcarcinomawithpathologicalstaget13n0m0
AT huangyangyu postoperativesurvivaleffectofthenumberofexaminedlymphnodesonesophagealsquamouscellcarcinomawithpathologicalstaget13n0m0
AT linpeng postoperativesurvivaleffectofthenumberofexaminedlymphnodesonesophagealsquamouscellcarcinomawithpathologicalstaget13n0m0
AT longhao postoperativesurvivaleffectofthenumberofexaminedlymphnodesonesophagealsquamouscellcarcinomawithpathologicalstaget13n0m0
AT zhanglanjun postoperativesurvivaleffectofthenumberofexaminedlymphnodesonesophagealsquamouscellcarcinomawithpathologicalstaget13n0m0
AT maqilong postoperativesurvivaleffectofthenumberofexaminedlymphnodesonesophagealsquamouscellcarcinomawithpathologicalstaget13n0m0
AT qiulihong postoperativesurvivaleffectofthenumberofexaminedlymphnodesonesophagealsquamouscellcarcinomawithpathologicalstaget13n0m0
AT maguowei postoperativesurvivaleffectofthenumberofexaminedlymphnodesonesophagealsquamouscellcarcinomawithpathologicalstaget13n0m0